Dissecting the damage in Northern Greek patients with childhood-onset systemic lupus erythematosus: a retrospective cohort study

被引:0
|
作者
Artemis Koutsonikoli
Maria Trachana
Anna-Bettina Heidich
Vasiliki Galanopoulou
Polyxeni Pratsidou-Gertsi
Alexandros Garyphallos
机构
[1] Aristotle University,1st Department of Pediatrics, Pediatric Immunology and Rheumatology Referral Center, Hippokration Hospital
[2] Aristotle University,Department of Hygiene and Epidemiology
[3] Papageorgiou Hospital,Rheumatology Department
[4] Aristotle University,4th Department of Internal Medicine, Hippokration Hospital
来源
关键词
Childhood Lupus; Damage; SDI;
D O I
暂无
中图分类号
学科分类号
摘要
The improved survival of childhood-onset systemic lupus erythematosus (cSLE) has resulted in longer patients’ exposure to disease inflammation, medications and/or comorbid diseases, which can all contribute to the development of organ damage. The aim of this study was to assess the evolution of damage accrual in cSLE patients overtime and investigate for predisposing factors. Disease characteristics and treatment in 47 Northern Greek Caucasian cSLE patients were retrospectively reviewed. The Systemic Lupus International Collaboration Clinics/American College of Rheumatology Damage Index (SDI) was used for damage assessment and the European Consensus Lupus Activity Measurement (ECLAM) to monitor cSLE activity. After a median disease duration of 7.4 years, 17/47 patients (36 %) had developed damage (SDI > 0). The most frequent domains damaged were the ocular (41 %), neuropsychiatric (35 %) and peripheral vascular (35 %) one. Peripheral vascular and neuropsychiatric damage was seen more frequently during the first 5 years of the disease. Longer exposure to azathioprine was associated with higher SDI at the end of follow-up (β = 0.008 for every additional month of use, p = 0.041). The mean annual flare frequency was associated with a shorter time interval until the development of the first damage (hazard’s ratio, HR 2.38 for each unit of increase, p = 0.018), while hydroxychloroquine use was associated with longer time interval (HR 0.19, p = 0.007). The lower rates of damage accrual in this study compared to other cohorts might be due to milder disease phenotype in Greek Caucasian cSLE patients, prompt diagnosis and effective disease control. Damage was noticed early in the disease course, and one-third of patients had an SDI > 0 at study completion. Disease flares and a severe disease course leading to prolonged use of immunosuppressives were significant risk factors, while hydroxychloroquine use was protective against cSLE damage accrual.
引用
收藏
页码:1225 / 1232
页数:7
相关论文
共 50 条
  • [41] NEUROPSYCHIATRIC MANIFESTATIONS IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: RETROSPECTIVE STUDY IN ONE SINGLE CENTER
    Kaleda, Maria
    Nikishina, Irina
    Glukhova, Svetlana
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1980 - 1980
  • [42] Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study
    Sit, Jacqueline K. K.
    Chan, Winnie K. Y.
    PEDIATRIC RHEUMATOLOGY, 2018, 16 : 56
  • [43] Autoimmune hepatitis in 847 childhood-onset systemic lupus erythematosus population: a multicentric cohort study
    Verena A. Balbi
    Bárbara Montenegro
    Ana C. Pitta
    Ana R. Schmidt
    Sylvia C. Farhat
    Laila P. Coelho
    Juliana C. O. Ferreira
    Rosa M. R. Pereira
    Maria T. Terreri
    Claudia Saad-Magalhães
    Nadia E. Aikawa
    Ana P. Sakamoto
    Kátia Kozu
    Lucia M. Campos
    Adriana M. Sallum
    Virginia P. Ferriani
    Daniela P. Piotto
    Eloisa Bonfá
    Clovis A. Silva
    Advances in Rheumatology, 58
  • [44] Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus
    Sakamoto, Ana P.
    Silva, Clovis A.
    Islabao, Aline G.
    Novak, Glaucia, V
    Molinari, Beatriz
    Nogueira, Paulo K.
    Pereira, Rosa M. R.
    Saad-Magalhaes, Claudia
    Clemente, Gleice
    Piotto, Daniela P.
    Aikawa, Nadia E.
    Pitta, Ana C.
    Trindade, Vitor C.
    Appenzeller, Simone
    Carvalho, Luciana M.
    Rabelo-Junior, Carlos N.
    Fonseca, Adriana R.
    Sztajnbok, Flavio R.
    Santos, Maria C.
    Bica, Blanca E.
    Sena, Evaldo G.
    Moraes, Ana J.
    Fraga, Melissa M.
    Robazzi, Teresa C.
    Spelling, Paulo F.
    Scheibel, Iloite M.
    Cavalcanti, Andre S.
    Matos, Erica N.
    Guimaraes, Luciano J.
    Santos, Flavia P.
    Mota, Licia M. H.
    Bonfa, Eloisa
    Terreri, Maria T.
    PEDIATRIC NEPHROLOGY, 2023, 38 (06) : 1843 - 1854
  • [45] Outcome of adult Saudi patients with childhood-onset systemic lupus erythematosus
    Al Hamzi, H.
    Alhaymouni, B.
    Al Shaikh, A.
    Al-Mayouf, S. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : 984 - 988
  • [46] Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study
    Jacqueline K. K. Sit
    Winnie K. Y. Chan
    Pediatric Rheumatology, 16
  • [47] Uveitis in childhood-onset systemic lupus erythematosus patients: a multicenter survey
    Kahwage, Paola Pinheiro
    Leme Ferriani, Mariana Paes
    Furtado, Joao M.
    de Carvalho, Luciana Martins
    Pileggi, Gecilmara Salviato
    Rodrigues Gomes, Francisco Hugo
    Terreri, Maria Teresa
    Magalhaes, Claudia Saad
    Rodrigues Pereira, Rosa Maria
    Sacchetti, Silvana Brasilia
    Marini, Roberto
    Bonfa, Eloisa
    Silva, Clovis Artur
    Leme Ferriani, Virginia Paes
    CLINICAL RHEUMATOLOGY, 2017, 36 (03) : 547 - 553
  • [48] Uveitis in childhood-onset systemic lupus erythematosus patients: a multicenter survey
    Paola Pinheiro Kahwage
    Mariana Paes Leme Ferriani
    João M. Furtado
    Luciana Martins de Carvalho
    Gecilmara Salviato Pileggi
    Francisco Hugo Rodrigues Gomes
    Maria Teresa Terreri
    Claudia Saad Magalhães
    Rosa Maria Rodrigues Pereira
    Silvana Brasilia Sacchetti
    Roberto Marini
    Eloisa Bonfá
    Clovis Artur Silva
    Virgínia Paes Leme Ferriani
    Clinical Rheumatology, 2017, 36 : 547 - 553
  • [49] Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus
    Colin Thorbinson
    Louise Oni
    Eve Smith
    Angela Midgley
    Michael W. Beresford
    Pediatric Drugs, 2016, 18 : 181 - 195
  • [50] Liver and spleen biometrics in childhood-onset systemic lupus erythematosus patients
    Andressa Guariento
    Marco F Silva
    Priscilla SF Tassetano
    Sílvia M Rocha
    Lúcia M Campos
    Marcelo Valente
    Clovis A Silva
    Pediatric Rheumatology, 12 (Suppl 1)